24/7 Market News Snapshot 20 May, 2024 – Kintara Therapeutics (NASDAQ: KTRA)
DENVER, Colo., 20 May, 2024 (247marketnews.com)- Kintara Therapeutics Inc (NASDAQ:KTRA) opened at $0.17 and is currently trading at $0.161 with a volume of 32.7M. The previous session closed at $0.143, indicating a positive momentum. The price has risen by 12.308% since Friday’s close. This suggests strong buying interest and potential further price appreciation. Technical indicators may support this bullish trend, making Kintara Therapeutics (NASDAQ:KTRA) an attractive opportunity for investors seeking higher returns. Traders should monitor the price action closely for potential profit-taking or trend reversal signals.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (KTRA)
- kintara therapeutics announces correction to prior announcement regarding 1-for-35 reverse stock split in connection with the proposed merger with tuhura biosciences to close on october 18, 2024
- kintara therapeutics announces 1-for-35 reverse stock split in connection with the proposed merger with tuhura biosciences
- kintara therapeutics announces correction to prior announcement regarding cvr issuance in connection with the proposed merger with tuhura biosciences expected to close on october 18, 2024
- kintara therapeutics announces record date for cvr issuance in connection with the proposed merger with tuhura biosciences expected to close on october 18, 2024
- kintara therapeutics announces fiscal 2024 financial results and provides corporate update